Lorin E. Olson

2.1k total citations
31 papers, 1.6k citations indexed

About

Lorin E. Olson is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Lorin E. Olson has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Genetics. Recurrent topics in Lorin E. Olson's work include Fibroblast Growth Factor Research (4 papers), Congenital heart defects research (3 papers) and Mesenchymal stem cell research (3 papers). Lorin E. Olson is often cited by papers focused on Fibroblast Growth Factor Research (4 papers), Congenital heart defects research (3 papers) and Mesenchymal stem cell research (3 papers). Lorin E. Olson collaborates with scholars based in United States, China and Germany. Lorin E. Olson's co-authors include Philippe Soriano, Tomoaki Iwayama, William L. Berry, Jessica Tollkühn, Chengyi Sun, Longbiao Yao, Michael G. Rosenfeld, Jonathan D. Wren, Chaoyong He and David W. Rose and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Lorin E. Olson

30 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorin E. Olson United States 19 833 222 218 202 201 31 1.6k
Yucheng Yao United States 25 898 1.1× 323 1.5× 153 0.7× 314 1.6× 155 0.8× 56 2.1k
Jirko Kühnisch Germany 17 478 0.6× 244 1.1× 153 0.7× 146 0.7× 162 0.8× 38 1.3k
Makoto Migita Japan 19 640 0.8× 269 1.2× 232 1.1× 470 2.3× 228 1.1× 70 1.8k
Xuezhong Qin United States 21 746 0.9× 192 0.9× 137 0.6× 114 0.6× 93 0.5× 36 1.5k
Keith Foster United Kingdom 21 1.3k 1.6× 335 1.5× 215 1.0× 349 1.7× 73 0.4× 32 2.2k
Gilbert-André Keller United States 14 1.0k 1.3× 144 0.6× 128 0.6× 196 1.0× 58 0.3× 17 1.9k
Jenna N. Regan United States 14 868 1.0× 129 0.6× 119 0.5× 224 1.1× 102 0.5× 27 1.3k
Catherine E. Winbanks Australia 16 1.9k 2.2× 139 0.6× 353 1.6× 197 1.0× 112 0.6× 21 2.5k
Cécile Duplàa France 27 1.3k 1.6× 133 0.6× 121 0.6× 522 2.6× 126 0.6× 54 2.3k
Fumiko Itoh Japan 26 2.2k 2.6× 215 1.0× 122 0.6× 311 1.5× 82 0.4× 56 3.0k

Countries citing papers authored by Lorin E. Olson

Since Specialization
Citations

This map shows the geographic impact of Lorin E. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorin E. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorin E. Olson more than expected).

Fields of papers citing papers by Lorin E. Olson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorin E. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorin E. Olson. The network helps show where Lorin E. Olson may publish in the future.

Co-authorship network of co-authors of Lorin E. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Lorin E. Olson. A scholar is included among the top collaborators of Lorin E. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorin E. Olson. Lorin E. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olson, Lorin E., et al.. (2025). Imatinib on target in stroke recovery. Journal of Clinical Investigation. 135(5). 1 indexed citations
2.
Olson, Lorin E., et al.. (2025). PDGFRα signaling regulates cartilage and fibrous tissue differentiation during synovial joint development. Nature Communications. 16(1). 4041–4041.
3.
Iwayama, Tomoaki, Kazuya Miyashita, Hiromi Sakashita, et al.. (2022). Plap-1 lineage tracing and single-cell transcriptomics reveal cellular dynamics in the periodontal ligament. Development. 149(19). 18 indexed citations
4.
Yao, Longbiao, Hiromi Sakashita, Jang Kim, et al.. (2022). Temporal control of PDGFRα regulates the fibroblast-to-myofibroblast transition in wound healing. Cell Reports. 40(7). 111192–111192. 39 indexed citations
5.
Nandadasa, Sumeda, Anna O’Donnell, Yu Yamaguchi, et al.. (2021). The versican-hyaluronan complex provides an essential extracellular matrix niche for Flk1+ hematoendothelial progenitors. Matrix Biology. 97. 40–57. 23 indexed citations
6.
Buhl, Eva Miriam, Sonja Djudjaj, Barbara M. Klinkhammer, et al.. (2020). Dysregulated mesenchymal PDGFR‐β drives kidney fibrosis. EMBO Molecular Medicine. 12(3). e11021–e11021. 53 indexed citations
7.
Carr, T.E.F., J. Wetter, Andrew E. Williams, et al.. (2020). The BCL-xL/BCL-2 Inhibitor Navitoclax Targets Myofibroblasts and Reduces Idiopathic Pulmonary Fibrosis (IPF) in Pre-Clinical Models. A2296–A2296. 1 indexed citations
8.
Sun, Chengyi, Hiromi Sakashita, Jang Kim, et al.. (2020). Mosaic Mutant Analysis Identifies PDGFRα/PDGFRβ as Negative Regulators of Adipogenesis. Cell stem cell. 26(5). 707–721.e5. 46 indexed citations
9.
Cha, Boksik, Xin Geng, Md. Riaj Mahamud, et al.. (2018). Complementary Wnt Sources Regulate Lymphatic Vascular Development Via PROX1-Dependent Wnt/β-Catenin Signaling. SSRN Electronic Journal. 1 indexed citations
10.
Cha, Boksik, Xin Geng, Md. Riaj Mahamud, et al.. (2018). Complementary Wnt Sources Regulate Lymphatic Vascular Development via PROX1-Dependent Wnt/β-Catenin Signaling. Cell Reports. 25(3). 571–584.e5. 54 indexed citations
11.
He, Chaoyong, Jang Kim, Chengyi Sun, et al.. (2017). STAT1 modulates tissue wasting or overgrowth downstream from PDGFRβ. Genes & Development. 31(16). 1666–1678. 30 indexed citations
12.
He, Xuemin, Rui Cheng, Kyoungmin Park, et al.. (2016). Pigment epithelium-derived factor, a noninhibitory serine protease inhibitor, is renoprotective by inhibiting the Wnt pathway. Kidney International. 91(3). 642–657. 27 indexed citations
13.
Zou, Hongyan, Rui Feng, Yong Huang, et al.. (2015). Double minute amplification of mutant PDGF receptor α in a mouse glioma model. Scientific Reports. 5(1). 8468–8468. 11 indexed citations
14.
Iwayama, Tomoaki, Longbiao Yao, Mikhail G. Dozmorov, et al.. (2015). PDGFRα signaling drives adipose tissue fibrosis by targeting progenitor cell plasticity. Genes & Development. 29(11). 1106–1119. 129 indexed citations
15.
Iwayama, Tomoaki & Lorin E. Olson. (2013). Involvement of PDGF in Fibrosis and Scleroderma: Recent Insights from Animal Models and Potential Therapeutic Opportunities. Current Rheumatology Reports. 15(2). 304–304. 50 indexed citations
16.
Sun, Ye, Ian Teng, Michael G. Rosenfeld, et al.. (2012). Asymmetric requirement of surface epithelial β‐catenin during the upper and lower jaw development. Developmental Dynamics. 241(4). 663–674. 13 indexed citations
17.
Greif, Daniel M., Maya E. Kumar, Janet K. Lighthouse, et al.. (2012). Radial Construction of an Arterial Wall. Developmental Cell. 23(3). 482–493. 69 indexed citations
18.
Olson, Lorin E. & Philippe Soriano. (2011). PDGFRβ Signaling Regulates Mural Cell Plasticity and Inhibits Fat Development. Developmental Cell. 20(6). 815–826. 154 indexed citations
19.
Olson, Lorin E. & Philippe Soriano. (2009). Increased PDGFRα Activation Disrupts Connective Tissue Development and Drives Systemic Fibrosis. Developmental Cell. 16(2). 303–313. 201 indexed citations
20.
Olson, Lorin E., Jessica Tollkühn, Claudio Scafoglio, et al.. (2006). Homeodomain-Mediated β-Catenin-Dependent Switching Events Dictate Cell-Lineage Determination. Cell. 125(3). 593–605. 220 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026